Letter to the Editor

Ulinastatin and Thymosin a1 Therapy in Adult Patients with Severe Sepsis: A Meta-analysis with Trial Sequential Analysis of Randomized Controlled Trials

Abstract

Ulinastatin and Thymosin a1 Therapy in Adult Patients with Se-vere Sepsis: A Meta-analysis with Trial Sequential Analysis of Randomized Controlled Trials

Di Carlo JV, Alexander SR (2005). Hemofil-tration for cytokine-driven illnesses: the mediator delivery hypothesis. Int J Artif Organs, 28 (8): 777–786.

The Cooperative Group of Immunomodula-tory Therapy of Sepsis, Lin HY (2007). Clinical trial with a new immunomodula-tory strategy: treatment of severe sepsis with Ulinastatin and Maipuxin. Zhonghua Yi Xue Za Zhi, 87 (7): 451-457. (In Chi-nese)

Zhang Y, Chen H, Li YM, Zheng SS, Chen YG, Liu LJ, Zhou L, Xie HY, Praseedom RK (2008). Thymosin alpha1 and ulinas-tatin based immunomodulatory strategy for sepsis arising from intra-abdominal infection due to carbapenem resistant bacteria. J Infect Dis, 198 (5): 723-30.

Chen H, He MY, Li YM (2009). Treatment of patients with severe sepsis using ulinas-tatin and thymosin alpha1: a prospective, randomized, controlled pilot study. Chin Med J (Engl), 122 (8): 883-8.

Su L, Meng FS, Tang YQ, Wen Q, Liu YS, Tang LQ, Duan PK, Luo RJ (2009). Clin-ical effects of ulinastatin and thymosin alpha1 on immune-modulation in septic patients. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, 21(3):147-50. (In Chinese).

Files
IssueVol 45 No 9 (2016) QRcode
SectionLetter to the Editor
Keywords
No keywords##
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
FAN H, ZHAO Y, ZHU JH, YE JH, YAO XQ. Ulinastatin and Thymosin a1 Therapy in Adult Patients with Severe Sepsis: A Meta-analysis with Trial Sequential Analysis of Randomized Controlled Trials. Iran J Public Health. 2016;45(9):1234-1235.